These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 8383919

  • 1. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G, Prosser BL.
    Am J Med; 1993 Mar 22; 94(3A):2S-8S. PubMed ID: 8383919
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B, Navarro F, Miró E, Coll R, Xicota MA, Prats G.
    Drugs Exp Clin Res; 1995 Mar 22; 21(4):129-38. PubMed ID: 8529525
    [Abstract] [Full Text] [Related]

  • 3. Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
    Prosser BL, Beskid G.
    Diagn Microbiol Infect Dis; 1995 Jan 22; 21(1):33-45. PubMed ID: 7789095
    [Abstract] [Full Text] [Related]

  • 4. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 Jan 22; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 5. A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents.
    Markowitz SM, Williams DS, Hanna CB, Parker JL, Pierce MA, Steele JC.
    Chemotherapy; 1995 Jan 22; 41(6):477-86. PubMed ID: 8529440
    [Abstract] [Full Text] [Related]

  • 6. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Jan 22; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 7. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL, Fuchs PC.
    J Chemother; 1997 Feb 22; 9(1):9-16. PubMed ID: 9106012
    [Abstract] [Full Text] [Related]

  • 8. [In vitro evaluation of lomefloxacin].
    Dette GA, Knothe H.
    Arzneimittelforschung; 1989 Aug 22; 39(8):832-5. PubMed ID: 2818672
    [Abstract] [Full Text] [Related]

  • 9. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB, Swanson RN.
    Drugs Exp Clin Res; 1988 Aug 22; 14(6):375-8. PubMed ID: 3145851
    [Abstract] [Full Text] [Related]

  • 10. Cross-resistance and cross-susceptibility between fluoroquinolone agents.
    Barry AL, Fuchs PC.
    Eur J Clin Microbiol Infect Dis; 1991 Dec 22; 10(12):1013-8. PubMed ID: 1666360
    [Abstract] [Full Text] [Related]

  • 11. Selection of a fluoroquinolone-class disk for susceptibility tests.
    Barry AL, Fuchs PC.
    Am J Med; 1993 Mar 22; 94(3A):17S-22S. PubMed ID: 8383918
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of fleroxacin, two other quinolones and three board-spectrum beta-lactams using the E-Test.
    Sobottka I, Neumann S, Laufs R.
    Chemotherapy; 1994 Mar 22; 40(5):293-8. PubMed ID: 7956451
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W.
    Chemotherapy; 1998 Mar 22; 44(2):77-84. PubMed ID: 9551236
    [Abstract] [Full Text] [Related]

  • 14. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
    Pattyn SR.
    Int J Lepr Other Mycobact Dis; 1991 Dec 22; 59(4):613-7. PubMed ID: 1666402
    [Abstract] [Full Text] [Related]

  • 15. Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria.
    Cormican MG, Jones RN.
    J Antimicrob Chemother; 1995 Aug 22; 36(2):431-4. PubMed ID: 8522474
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2007 May 22; 58(1):27-32. PubMed ID: 17383140
    [Abstract] [Full Text] [Related]

  • 17. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
    Soussy CJ, Le Van Thoi J, Morel C, Acar JF, Thabaut A, Fleurette J, Vallée E, Dabernat H, Chanal M, Drugeon H.
    Pathol Biol (Paris); 1990 May 22; 38(5):390-6. PubMed ID: 2195448
    [Abstract] [Full Text] [Related]

  • 18. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons.
    Pfaller MA, Beach ML, Gordon KA, Jones RN.
    J Chemother; 2002 Feb 22; 14(1):13-8. PubMed ID: 11892893
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
    Rotstein C, Amsterdam D, Beam TR, Mandell LA, Gorzynski EA.
    Diagn Microbiol Infect Dis; 1993 Jul 22; 17(1):85-91. PubMed ID: 8395375
    [Abstract] [Full Text] [Related]

  • 20. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
    Kawahara S, Kamisaka K, Tada A, Nakada H, Mishima Y, Yoshimoto S, Matsuyama T, Kibata M, Nagare J.
    Kekkaku; 1991 Jun 22; 66(6):429-31. PubMed ID: 1942726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.